6 results
Summary of characteristics of Platelet Aggregation Inhibitors

#AntiPlatelet #Inhibitors #Pharmacology #Table #Overview #Interactions #Pharmacology #Cardiology
Platelet Aggregation Inhibitors ... #AntiPlatelet #Inhibitors ... #Pharmacology # ... Table #Overview ... #Cardiology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Between Oral P2Y12 Inhibitors ... A, Switching between ... administration of a loading ... .117.031164 #P2Y12 #Inhibitor ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Conversion - P2Y12 Inhibitor ... • Irreversible inhibitor ... • Reversible inhibitor ... Conversion #P2Y12 #Inhibitor ... #Switching #pharmacology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
inducers (↑) and inhibitors ... concentrations, and inhibitors ... by inducers or inhibitors ... Pglycoprotein #inducers #inhibitors ... #Pharmacology
Antibiotic classification refers to the categorization of antibiotics based on their chemical structure, mechanism of action,
wall synthesis inhibitors ... Protein synthesis inhibitors ... DNA synthesis inhibitors ... RNA synthesis inhibitors ... Metabolic inhibitors
Clinically Significant Cardiovascular Drug-Drug Interactions With OTC Supplements and Herbal Products
Angiotensin-Converting Enzyme Inhibitors (ACEIs)
 • Night-blooming
Angiotensin-Converting Enzyme Inhibitors ... alpha-blockers, leading ... Monoamine Oxidase Inhibitors ... supplementals #herbal #pharmacology ... #DDI #table #cardiology